Logo image of GP

GREENPOWER MOTOR CO INC (GP) Stock Fundamental Analysis

USA - NASDAQ:GP - CA39540E3023 - Common Stock

3.96 USD
+0.57 (+16.81%)
Last: 9/17/2025, 8:00:01 PM
3.96 USD
0 (0%)
After Hours: 9/17/2025, 8:00:01 PM
Fundamental Rating

1

Taking everything into account, GP scores 1 out of 10 in our fundamental rating. GP was compared to 128 industry peers in the Machinery industry. Both the profitability and financial health of GP have multiple concerns. GP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GP had negative earnings in the past year.
GP had a negative operating cash flow in the past year.
GP had negative earnings in each of the past 5 years.
In the past 5 years GP always reported negative operating cash flow.
GP Yearly Net Income VS EBIT VS OCF VS FCFGP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M

1.2 Ratios

GP has a Return On Assets of -52.31%. This is amonst the worse of the industry: GP underperforms 89.06% of its industry peers.
Industry RankSector Rank
ROA -52.31%
ROE N/A
ROIC N/A
ROA(3y)-39.16%
ROA(5y)-33.5%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GP Yearly ROA, ROE, ROICGP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K 4K 5K

1.3 Margins

GP's Gross Margin of 12.70% is on the low side compared to the rest of the industry. GP is outperformed by 87.50% of its industry peers.
GP's Gross Margin has declined in the last couple of years.
GP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.05%
GM growth 5Y-18.09%
GP Yearly Profit, Operating, Gross MarginsGP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5K -10K -15K -20K -25K

More info and screens

0

2. Health

2.1 Basic Checks

GP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GP has been increased compared to 1 year ago.
The number of shares outstanding for GP has been increased compared to 5 years ago.
GP has a worse debt/assets ratio than last year.
GP Yearly Shares OutstandingGP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
GP Yearly Total Debt VS Total AssetsGP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -4.33, we must say that GP is in the distress zone and has some risk of bankruptcy.
GP has a worse Altman-Z score (-4.33) than 88.28% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.33
ROIC/WACCN/A
WACC8.37%
GP Yearly LT Debt VS Equity VS FCFGP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M -20M 30M

2.3 Liquidity

A Current Ratio of 1.29 indicates that GP should not have too much problems paying its short term obligations.
GP's Current ratio of 1.29 is on the low side compared to the rest of the industry. GP is outperformed by 82.03% of its industry peers.
A Quick Ratio of 0.07 indicates that GP may have some problems paying its short term obligations.
With a Quick ratio value of 0.07, GP is not doing good in the industry: 94.53% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 0.07
GP Yearly Current Assets VS Current LiabilitesGP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

5

3. Growth

3.1 Past

GP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -128.78%.
Looking at the last year, GP shows a very negative growth in Revenue. The Revenue has decreased by -25.47% in the last year.
Measured over the past years, GP shows a quite strong growth in Revenue. The Revenue has been growing by 8.01% on average per year.
EPS 1Y (TTM)-128.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)-25.47%
Revenue growth 3Y4.81%
Revenue growth 5Y8.01%
Sales Q2Q%-48.3%

3.2 Future

Based on estimates for the next years, GP will show a very strong growth in Earnings Per Share. The EPS will grow by 39.88% on average per year.
The Revenue is expected to grow by 70.92% on average over the next years. This is a very strong growth
EPS Next Y91.64%
EPS Next 2Y39.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year52.4%
Revenue Next 2Y70.92%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GP Yearly Revenue VS EstimatesGP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
GP Yearly EPS VS EstimatesGP Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GP. In the last year negative earnings were reported.
Also next year GP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GP Price Earnings VS Forward Price EarningsGP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GP Per share dataGP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

GP's earnings are expected to grow with 39.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.88%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREENPOWER MOTOR CO INC

NASDAQ:GP (9/17/2025, 8:00:01 PM)

After market: 3.96 0 (0%)

3.96

+0.57 (+16.81%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)11-12 2025-11-12
Inst Owners3.91%
Inst Owner Change6.8%
Ins Owners22.12%
Ins Owner ChangeN/A
Market Cap12.08M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short Ratio0.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.25%
Min EPS beat(2)9.39%
Max EPS beat(2)21.12%
EPS beat(4)3
Avg EPS beat(4)8.35%
Min EPS beat(4)-0.03%
Max EPS beat(4)21.12%
EPS beat(8)4
Avg EPS beat(8)-10.02%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-62.38%
Min Revenue beat(2)-80.96%
Max Revenue beat(2)-43.79%
Revenue beat(4)1
Avg Revenue beat(4)-26.8%
Min Revenue beat(4)-80.96%
Max Revenue beat(4)24.04%
Revenue beat(8)1
Avg Revenue beat(8)-32.83%
Revenue beat(12)3
Avg Revenue beat(12)-19.69%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-21.74%
EPS NY rev (1m)-17.89%
EPS NY rev (3m)-17.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-23.64%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-20.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.66
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-6.2
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-1.38
FCFYN/A
OCF(TTM)-1.37
OCFYN/A
SpS6.03
BVpS-1.7
TBVpS-1.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -52.31%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.7%
FCFM N/A
ROA(3y)-39.16%
ROA(5y)-33.5%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.05%
GM growth 5Y-18.09%
F-Score2
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.31%
Cap/Sales 0.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 0.07
Altman-Z -4.33
F-Score2
WACC8.37%
ROIC/WACCN/A
Cap/Depr(3y)17.9%
Cap/Depr(5y)43.07%
Cap/Sales(3y)0.75%
Cap/Sales(5y)1.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-128.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y91.64%
EPS Next 2Y39.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.47%
Revenue growth 3Y4.81%
Revenue growth 5Y8.01%
Sales Q2Q%-48.3%
Revenue Next Year52.4%
Revenue Next 2Y70.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-93.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-118.39%
OCF growth 3YN/A
OCF growth 5YN/A